Clinical trial
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion: a Randomized Controlled Multi-center Trial
NCT04166331 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion: a Randomized Controlled Multi-center Trial
- Lead sponsor
- University Hospital, Limoges
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 20, 2020
- Completion date
- July 1, 2025
- Enrollment
- 136 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.
cardiomyopathies, hypoperfusion, left ventricular systolic dysfunction, sepsis